Joseph Taylor is a Psychiatry physician. ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Testing a Transdiagnostic TMS Treatment Target
Sponsor: Brigham and Women's Hospital
- Individualized Functional Connectivity Targeting in aiTBS for Depression
Sponsor: Brigham and Women's Hospital
- Role of the Supraspinal Opioidergic Circuit in Prefrontal TMS-Induced Analgesia
Sponsor: Medical University of South Carolina
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%SSRI26.1%Sertraline Hcl52%Trazodone Hcl48%Part D<11 patientsAtypical Antipsychotic26.1%Aripiprazole52%Quetiapine Fumarate48%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1986–2026 per NIH RePORTER. The latest:
- Imaging- vs. scalp-targeted accelerated TMS for depression: The number needed to scan (NNS) trial
Brigham and Women'S Hospital
FY2026$863,825R01MH140916 - Deriving TMS Targets for Mood Valence and Mood Stabilization in Bipolar Disorder
Brigham and Women'S Hospital
FY2026$195,500K23MH129829 - Deriving TMS Targets for Mood Valence and Mood Stabilization in Bipolar Disorder
Brigham and Women'S Hospital
FY2025$195,500K23MH129829
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Nemeroff, MD
Dell Medical School
Dennis Charney, MD
Icahn School of Medicine at Mount Sinai
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”